DiviDrip · PHIO

PHIO — Phio Pharmaceuticals Corp.

PHIO is Phio Pharmaceuticals Corp. (Healthcare) — a non-dividend-paying stock. Trading at $1.08. Market cap: $13M. Capital Quality Rank: 8/100 — Systemic risk.

Stock snapshot

Price$1.08
Market cap$13M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)8 / 100 · Systemic risk
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About PHIO

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Listed2012Employees6HQKing Of Prussia, PASectorHealthcareWebsitephiopharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PHIO. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PHIO's current stock price?

PHIO (Phio Pharmaceuticals Corp.) is currently trading at $1.08.

Does PHIO pay a dividend?

PHIO (Phio Pharmaceuticals Corp.) does not currently pay a regular dividend.

What is PHIO's Capital Quality Rank?

PHIO has a Capital Quality Rank of 8/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PHIO in DiviDrip

Add PHIO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow